A recent investigation conducted by Iijima et al. (92) studied for the first time the expression of PD-1 in circulating CD4+ and CD8+ T cells from fulminant T1D onset to 12 weeks after initiation of treatment. This evidence concerns the gene CD8A and type 1 diabetes mellitus.